Author:
Law Sharon W. Y.,Wong Angel Y. S.,Anand Shweta,Wong Ian C. K.,Chan Esther W.
Funder
Research Grants Council of the Hong Kong Special Administrative Region, China
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference54 articles.
1. US Food and Drug Administration (FDA). Accolate (zafirlukast) product label. 2013.
http://www.fda.gov/Drugs
. Accessed 14 Nov 2016.
2. US Food and Drug Administration (FDA). Zyflo (zileuton) product label. 2012.
http://www.fda.gov/Drugs
. Accessed 14 Nov 2016.
3. US Food and Drug Administration (FDA). Singulair (montelukast sodium) product label. 2014.
http://www.fda.gov/Drugs
. Accessed 14 Nov 2016.
4. Biswas P, Wilton L, Pearce G, Freemantle S, Sharkir S, Mann RD. Pharmacosurveillance and safety of the leukotriene receptor antagonist (LTRA), montelukast. Clin Exp Allergy Rev. 2001;1(3):300–4.
5. Twaites BR, Wilton LV, Shakir SAW. Safety of zafirlukast: results of a postmarketing surveillance study on 7976 patients in England. Drug Saf. 2007;30(5):419–29.
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献